CDC has released supplemental information for providers about the 9-valent HPV vaccine. The document summarizes some of the recommendations included in the original Policy Note and provides additional guidance for issues that were not addressed previously but are likely to arise during the transition from quadrivalent HPV vaccine to 9-valent HPV vaccine.
Supplemental Information and Guidance for Vaccination Providers Regarding Use of 9-valent HPV Vaccine
Jul 21, 2015 | Alyson Jordan
Related Posts
- Mobilizing for Action through Planning and Partnerships (MAPP) Performance Improvement Workforce Development
Register to Attend a Mobilizing for Action through...
Registration is now open for NACCHO’s (MAPP) 2.0 training series.
May 07, 2024 | Andrea Grenadier
Register to Attend a Mobilizing for Action through...
- Funding Opportunity Health Equity & Social Justice Performance Improvement
RFP: Creating Tools that Facilitate Engagement of Local...
This RFP supports LHDs by creating tools that facilitate their engagement and...
May 06, 2024 | Andrea Grenadier
RFP: Creating Tools that Facilitate Engagement of Local...
- Tools & Resources Webinar Healthcare-Associated Infections Infection, Prevention, and Control
Webinar Recording: Multidrug-Resistant Organisms with...
A webinar recording is available for BUILD HAIAR’s March call on preventing and...
Apr 30, 2024 | Candice Young, Irene Halferty